# Ginger Menstrual Pain Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/ginger-menstrual-pain-meta-analysis-evidence-review
Category: evidence-review
Summary: Ginger Menstrual Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-06-08
Reviewed by: Migaku Evidence Review
# Ginger Menstrual Pain Meta-analysis: What the Evidence Says

## Quick Answer

Ginger Menstrual Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review | systematic review | 1 | 2026-02-27 | 10.1186/s13048-026-02030-z |
| Complementary and alternative therapies in the treatment of primary dysmenorrhea | narrative review | 3 | 2026-01-13 | 10.3389/frph.2025.1730164 |

## What The Sources Report

- PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance. [Dashti Sareh (2026); evidence level 1]
- Conventional pharmacological interventions, such as hormonal contraceptives, insulin sensitizers, and ovulation-inducing agents are effective in symptom control, but may be associated with side effects, contraindications, or limited patient adherence. [Dashti Sareh (2026); evidence level 1]
- NSAIDs have been found to be more effective than placebo in relieving pain in women with primary dysmenorrhea, but they increase the risk of adverse effects, such as mild neurological symptoms (headache, drowsiness, dizziness) and gastrointestinal symptoms (nausea, indigestion). [Ma Wenyi (2026); evidence level 3]
- However, when combined OCP is used, there is an additional deep vein thrombosis (DVT) in every 1,000 women, and a higher risk is observed in users aged 6-12 months before use and over 40 years old. [Ma Wenyi (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ginger menstrual pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dashti Sareh (2026). Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. DOI: 10.1186/s13048-026-02030-z. PMCID: PMC13041406. PMID: 41761211. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13041406/
- Ma Wenyi (2026). Complementary and alternative therapies in the treatment of primary dysmenorrhea. DOI: 10.3389/frph.2025.1730164. PMCID: PMC12835285. PMID: 41608300. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12835285/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.